The Clinicopathologic Significance of p53 and BAF250a (ARID1A) Expression in Clear Cell Carcinoma of the Endometrium

被引：0
|
作者：
Fadare, O.
Gwin, K.
Desouki, M. M.
Crispens, M. A.
Jones, H. W., III
Khabele, D.
Mohammed, K.
Liang, S. X.
Zheng, W.
Hecht, J. L.
Parkash, V.
机构：
[1] Vanderbilt Univ, Nashville, TN USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] UPMC, Pittsburgh, PA USA
[4] N Shore LIJ, Nhp, NY USA
[5] Univ Arizona, Tucson, AZ USA
[6] Harvard Univ, Boston, MA 02115 USA
[7] Yale Univ, New Haven, CT USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1138
引用
收藏
页码：273A / 273A
页数：1
相关论文
共 50 条
  • [1] The Clinicopathologic Significance of p53 and BAF250a (ARID1A) Expression in Clear Cell Carcinoma of the Endometrium
    Fadare, O.
    Gwin, K.
    Desouki, M. M.
    Crispens, M. A.
    Jones, H. W., III
    Khabele, D.
    Mohammed, K.
    Liang, S. X.
    Zheng, W.
    Hecht, J. L.
    Parkash, V.
    MODERN PATHOLOGY, 2013, 26 : 273A - 273A
  • [2] The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium
    Fadare, Oluwole
    Gwin, Katja
    Desouki, Mohamed M.
    Crispens, Marta A.
    Jones, Howard W., III
    Khabele, Dineo
    Liang, Sharon X.
    Zheng, Wenxin
    Mohammed, Khaled
    Hecht, Jonathan L.
    Parkash, Vinita
    MODERN PATHOLOGY, 2013, 26 (08) : 1101 - 1110
  • [3] The Clinicopathologic Significance of BAF250a (ARID1A) Expression in Hepatocellular Carcinoma
    Zhao, Jie
    Chen, Jiang
    Lin, Hui
    Jin, Renan
    Liu, Jinghua
    Liu, Xiaolong
    Meng, Ning
    Cai, Xiujun
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (03) : 453 - 459
  • [4] The Clinicopathologic Significance of the Loss of BAF250a ( ARID1A) Expression in Endometrial Carcinoma
    Zhang, Zheng-mao
    Xiao, Shuang
    Sun, Guang-yu
    Liu, Yue-ping
    Zhang, Feng-hua
    Yang, Hong-fang
    Li, Jia
    Qiu, Hong-bing
    Liu, Yang
    Zhang, Chao
    Kang, Shan
    Shan, Bao-en
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (03) : 534 - 540
  • [5] Loss of BAF250a (ARID1A) Expression in Endometrial Clear Cell Carcinoma: Assessment of Frequency and Clinicopathologic Implications
    Fadare, O.
    Renshaw, I. L.
    Liang, S. X.
    LABORATORY INVESTIGATION, 2012, 92 : 269A - 269A
  • [6] Loss of BAF250a (ARID1A) Expression in Endometrial Clear Cell Carcinoma: Assessment of Frequency and Clinicopathologic Implications
    Fadare, O.
    Renshaw, I. L.
    Liang, S. X.
    MODERN PATHOLOGY, 2012, 25 : 269A - 269A
  • [7] Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma
    Xiao, Wenbin
    Awadallah, Amad
    Xin, Wei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2012, 5 (07): : 642 - 650
  • [8] BAF250a (ARID1A) Expression in Ovarian Clear Cell Adenocarcinoma with an Adenofibromatous Component
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Kisimoto, T.
    Fugo, K.
    Shozu, M.
    MODERN PATHOLOGY, 2013, 26 : 289A - 290A
  • [9] BAF250a (ARID1A) Expression in Ovarian Clear Cell Adenocarcinoma with an Adenofibromatous Component
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Kisimoto, T.
    Fugo, K.
    Shozu, M.
    LABORATORY INVESTIGATION, 2013, 93 : 289A - 290A
  • [10] Loss of ARID1A/BAF250a expression in endometriosis
    Noske, A.
    Samartzis, N.
    Rechsteiner, M.
    Samartzis, E.
    Imesch, P.
    Caduff, R.
    Moch, H.
    HISTOPATHOLOGY, 2012, 61 : 108 - 108
12345